NASDAQ:PCRX
Pacira Pharmaceuticals, Inc.
(NASDAQ:PCRX)
57.07
-1.56
(-2.66%)
As of 2022-06-30, 03:10 PM (EST)
| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
IRAM2022Team4 • IRAM 2022 • Feb 2022
PCRX has already established itself as a leader in non-opioid pain management industry in the USA and they plan to become a global brand once they begin commercialization in Europe, Canada and China. With this we are looking at a 30% total market growth upon successful commercialization in these countries. The company is looking to penetrate the pediatrics market where 20% of orthopedic surgeries are pediatric patients, this will give them roughly $20M added revenue starting in 2022.
ACTION
TICKER
SHARES
STATUS
alonsona • Stockfuse Continuum (US) • Dec 2021
Automatic trade executed by Stockfuse to ensure margin compliance.
ACTION
TICKER
SHARES
STATUS
LakkoKassa • OLD|Aalto Investment Management Game (Spring 2020) • Mar 2020
Closing position
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS
ACTION
TICKER
SHARES
STATUS